Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Ottawa
$105,000.00
Defining a network of genes directly and indirectly regulated by beta-catenin
FY 2009-10
Summary
Duchenne muscular dystrophy (DMD), a disorder that causes progressive muscle wasting and weakness, and sarcopaenia, defined as muscle wasting associated with disease and aging, are amongst other genetic diseases that result in the loss of functional muscle tissue. To this day, there is no effective treatment available for muscular dystrophy. What are available are conventional therapeutic options such as physiotherapy, to prevent contractures, surgery, to prevent spinal curvature, and medications, to try and relieve some pain. The idea of using embryonic stem cells has attracted great attention and show promise for future cell therapies. Embryonic stem (ES) cells are cell lines that were derived originally from the early stages of embryo formation. These cell lines have the potential to be studied for decades and are available readily for research purposes. ES cells have the potential to form every cell type that exists in the mouse, and for that reason one of the major limitations of ES cells are that we are limited in the amount of muscle we can produce, in comparison to other cell types. To obtain sufficient skeletal muscle, we need to gain a better understanding of the molecular mechanisms regulating muscle development in order to allow for a larger proportion of cells to form muscle. We propose to study the genes that allow a cell to become a muscle cell, specifically to identify the genes regulated by beta-catenin, a known protein to play a role in skeletal muscle formation. Both P19 cells (a model of mouse ES cells) and mouse ES cells will be used for this study. The ultimate goal is to enhance our mechanistic understanding of muscle formation in order to identify methods to enhance myogenesis in stem cells for future potential muscle repair/replacement strategies.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
206177
Name
Mehta Virja
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Defining a network of genes directly and indirectly regulated by beta-catenin
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Chip-Seq; Chromatin Immunoprecipitation; Differentiation; Immunofluorescence; Microarray; Muscular Dystrophy; P19s And Mouse Embryonic Stem Cells; Q-Pcr; Skeletal Muscle Development
Abstract
Duchenne muscular dystrophy (DMD), a disorder that causes progressive muscle wasting and weakness, and sarcopaenia, defined as muscle wasting associated with disease and aging, are amongst other genetic diseases that result in the loss of functional muscle tissue. To this day, there is no effective treatment available for muscular dystrophy. What are available are conventional therapeutic options such as physiotherapy, to prevent contractures, surgery, to prevent spinal curvature, and medications, to try and relieve some pain. The idea of using embryonic stem cells has attracted great attention and show promise for future cell therapies. Embryonic stem (ES) cells are cell lines that were derived originally from the early stages of embryo formation. These cell lines have the potential to be studied for decades and are available readily for research purposes. ES cells have the potential to form every cell type that exists in the mouse, and for that reason one of the major limitations of ES cells are that we are limited in the amount of muscle we can produce, in comparison to other cell types. To obtain sufficient skeletal muscle, we need to gain a better understanding of the molecular mechanisms regulating muscle development in order to allow for a larger proportion of cells to form muscle. We propose to study the genes that allow a cell to become a muscle cell, specifically to identify the genes regulated by beta-catenin, a known protein to play a role in skeletal muscle formation. Both P19 cells (a model of mouse ES cells) and mouse ES cells will be used for this study. The ultimate goal is to enhance our mechanistic understanding of muscle formation in order to identify methods to enhance myogenesis in stem cells for future potential muscle repair/replacement strategies.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mehta, Virja
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~